Contact
searchSearch
HMP Global
Quiz

MACE Risk in Alopecia Areata: What Clinical Trials and Real-World Data Reveal

Riya Gandhi, MA
01/05/2026
© 2026 HMP Global. All Rights Reserved.
Any views and opinions expressed are those of the author(s) and/or participants and do not necessarily reflect the views, policy, or position of the Dermatology Learning Network or HMP Global, their employees, and affiliates.

Related Content

Quiz
Initiating JAK Inhibitors in AA: Screening, Safety, and Shared Decision-Making
01/15/2026
Riya Gandhi, MA
Test your knowledge of best practices before initiating JAK inhibitors for alopecia areata.
Test your knowledge of best practices before initiating JAK inhibitors for alopecia areata.
Test your knowledge of best...
01/15/2026
The Dermatologist
Quiz
Alopecia Areata Support Systems, Peer Networks, and Patient Misinformation
12/20/2025
Riya Gandhi, MA
How do you guide patients through peer-driven misinformation and anxiety-provoking online forums? Take this quiz to refine your approach to trusted resources and patient-centered reassurance.
How do you guide patients through peer-driven misinformation and anxiety-provoking online forums? Take this quiz to refine your approach to trusted resources and patient-centered reassurance.
How do you guide patients...
12/20/2025
The Dermatologist
melissa Piliang
Videos
JAK Inhibitors & Boxed Warnings
12/17/2025
Melissa Piliang, MD
Gain expert insight into the origins and implications of the boxed warning on JAK inhibitors for dermatologists treating alopecia areata. Learn about clinical trial data, patient selection, risk mitigation strategies, and the importance of...
Gain expert insight into the origins and implications of the boxed warning on JAK inhibitors for dermatologists treating alopecia areata. Learn about clinical trial data, patient selection, risk mitigation strategies, and the importance of...
Gain expert insight into the...
12/17/2025
The Dermatologist
Quiz
Etiological Communication, Atopy, and First-Visit Navigation in AA
12/10/2025
Riya Gandhi, MA
Master the first-visit conversation for AA patients. Quiz yourself on how to balance hope with realism, address comorbid atopy, and respond to the quest for deeper causality in autoimmune disease.
Master the first-visit conversation for AA patients. Quiz yourself on how to balance hope with realism, address comorbid atopy, and respond to the quest for deeper causality in autoimmune disease.
Master the first-visit...
12/10/2025
The Dermatologist

Popular Articles

AD
Quiz
Trivia: Atopic Dermatitis Patients With Alopecia Areata
02/28/2024
Riya Gandhi, MA
02/28/2024
The Dermatologist
Travis Blalock
Videos
Enhancing Dermatologic Surgery Skills: Insights and Strategies
04/01/2024
Travis W. Blalock, MD
In this interview, Dr Travis Blalock shares valuable insights on dermatologic surgery for non-Mohs surgeons. From identifying key surgical pearls to managing challenges like bleeding and tension, Blalock shares invaluable strategies and...
In this interview, Dr Travis Blalock shares valuable insights on dermatologic surgery for non-Mohs surgeons. From identifying key surgical pearls to managing challenges like bleeding and tension, Blalock shares invaluable strategies and...
In this interview, Dr Travis...
04/01/2024
The Dermatologist
skin cancer
News
Interferon-Gamma as a Prognostic Marker in Macroscopic Stage III Melanoma
05/08/2024
Jessica Garlewicz
Researchers aimed to identify prognostic and predictive biomarkers for adjuvant anti-PD-1 therapy in patients with macroscopic stage III melanoma.
Researchers aimed to identify prognostic and predictive biomarkers for adjuvant anti-PD-1 therapy in patients with macroscopic stage III melanoma.
Researchers aimed to identify...
05/08/2024
The Dermatologist
Actinic Keratosis
FDA Alerts
FDA Approves Almirall’s Klisyri for Expanded Treatment Area of Actinic Keratosis
06/11/2024
Riya Gandhi, MA
The US Food and Drug Administration (FDA) has recently approved an expansion for the use of Klisyri (tirbanibulin) to treat actinic keratosis (AK) on larger areas of the face or scalp, up to 100 cm².
The US Food and Drug Administration (FDA) has recently approved an expansion for the use of Klisyri (tirbanibulin) to treat actinic keratosis (AK) on larger areas of the face or scalp, up to 100 cm².
The US Food and Drug...
06/11/2024
The Dermatologist
psoriasis
News
Paradoxical Eczema in Patients Receiving Biologics for Psoriasis
07/26/2024
Jessica Garlewicz
Researchers utilized data from the British Association of Dermatologists Biologics and Immunomodulators Register, focusing on adults treated with biologics for plaque psoriasis.
Researchers utilized data from the British Association of Dermatologists Biologics and Immunomodulators Register, focusing on adults treated with biologics for plaque psoriasis.
Researchers utilized data from...
07/26/2024
The Dermatologist
dec 2025 Print Cover

Current Issue

December 2025
Volume 33
Issue 8
Current Issue
Issue Archive

Latest Quizzes and Trivia

Quiz
Initiating JAK Inhibitors in AA: Screening, Safety, and Shared Decision-Making
01/15/2026
Riya Gandhi, MA
Test your knowledge of best practices before initiating JAK inhibitors for alopecia areata.
Test your knowledge of best practices before initiating JAK inhibitors for alopecia areata.
Test your knowledge of best...
01/15/2026
The Dermatologist
Quiz
MACE Risk in Alopecia Areata: What Clinical Trials and Real-World Data Reveal
01/05/2026
Riya Gandhi, MA
This quiz examines which patients experienced MACE events in clinical trials and how real-world incidence data compares.
This quiz examines which patients experienced MACE events in clinical trials and how real-world incidence data compares.
This quiz examines which...
01/05/2026
The Dermatologist
Quiz
Why Higher JAK Doses Raise Safety Concerns in AD
01/01/2026
Riya Gandhi, MA
Dive into kinase dynamics—can you pinpoint the molecular reason behind increased adverse event risk with high-dose JAK inhibitor therapy?
Dive into kinase dynamics—can you pinpoint the molecular reason behind increased adverse event risk with high-dose JAK inhibitor therapy?
Dive into kinase dynamics—can...
01/01/2026
The Dermatologist
Quiz
What Drives Fibrosis in Chronic Atopic Dermatitis Lesions?
01/01/2026
Riya Gandhi, MA
Take the quiz to explore how fibroblasts respond to Type 2 cytokines in long-standing AD.
Take the quiz to explore how fibroblasts respond to Type 2 cytokines in long-standing AD.
Take the quiz to explore how...
01/01/2026
The Dermatologist
Quiz
Alopecia Areata Support Systems, Peer Networks, and Patient Misinformation
12/20/2025
Riya Gandhi, MA
How do you guide patients through peer-driven misinformation and anxiety-provoking online forums? Take this quiz to refine your approach to trusted resources and patient-centered reassurance.
How do you guide patients through peer-driven misinformation and anxiety-provoking online forums? Take this quiz to refine your approach to trusted resources and patient-centered reassurance.
How do you guide patients...
12/20/2025
The Dermatologist
acne
Quiz
Quiz: Acne Topical Therapy
12/18/2025
Jessica Garlewicz
Which advancement in topical acne therapy was highlighted as improving tolerability while maintaining efficacy?
Which advancement in topical acne therapy was highlighted as improving tolerability while maintaining efficacy?
Which advancement in topical...
12/18/2025
The Dermatologist
psoriasis
Quiz
Quiz: Clinical Clue in Psoriasis Diagnosis
12/18/2025
Jessica Garlewicz
What clinical clue should prompt a dermatologist to question the diagnosis of psoriasis, especially when highly effective agents fail?
What clinical clue should prompt a dermatologist to question the diagnosis of psoriasis, especially when highly effective agents fail?
What clinical clue should prompt...
12/18/2025
The Dermatologist
Quiz
Etiological Communication, Atopy, and First-Visit Navigation in AA
12/10/2025
Riya Gandhi, MA
Master the first-visit conversation for AA patients. Quiz yourself on how to balance hope with realism, address comorbid atopy, and respond to the quest for deeper causality in autoimmune disease.
Master the first-visit conversation for AA patients. Quiz yourself on how to balance hope with realism, address comorbid atopy, and respond to the quest for deeper causality in autoimmune disease.
Master the first-visit...
12/10/2025
The Dermatologist
Quiz
Clinical Benefit of Accurate Risk Stratification in cSCC Management
12/04/2025
Jessica Garlewicz
What is the primary clinical benefit of accurate risk stratification in cutaneous squamous cell carcinoma management?
What is the primary clinical benefit of accurate risk stratification in cutaneous squamous cell carcinoma management?
What is the primary clinical...
12/04/2025
The Dermatologist
Quiz
Investigative Urgency and Autoimmune Framing in AA
12/01/2025
Riya Gandhi, MA
Patients often seek extensive testing to “find the root cause” of AA. Take this quiz to sharpen your ability to guide these discussions.
Patients often seek extensive testing to “find the root cause” of AA. Take this quiz to sharpen your ability to guide these discussions.
Patients often seek extensive...
12/01/2025
The Dermatologist

HMP Global Products

Events

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2026 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Terms of Use